MARINOL CAP 10MG CAPSULE

Country: কানাডা

ভাষা: ইংরেজি

সূত্র: Health Canada

সক্রিয় উপাদান:

DRONABINOL

থেকে পাওয়া:

SOLVAY PHARMA INC

এটিসি কোড:

A04AD10

INN (International Name):

DRONABINOL

ডোজ:

10MG

ফার্মাসিউটিকাল ফর্ম:

CAPSULE

রচনা:

DRONABINOL 10MG

প্রশাসন রুট:

ORAL

প্যাকেজ ইউনিট:

60

প্রেসক্রিপশন টাইপ:

Narcotic (CDSA II)

Therapeutic area:

MISCELLANEOUS ANTIEMETICS

পণ্য সারাংশ:

Active ingredient group (AIG) number: 0116400002; AHFS:

অনুমোদন অবস্থা:

CANCELLED POST MARKET

অনুমোদন তারিখ:

2008-07-24

পণ্য বৈশিষ্ট্য

_N_
_MARINOL_
_® _
_ _
Page 1 of 31
PRODUCT MONOGRAPH
N
MARINOL
®
dronabinol (delta-9-tetrahydrocannabinol; ∆
9
-THC)
2.5 mg, 5 mg, and 10 mg capsules
Antiemetic
DATE OF PREPARATION:
December 3, 2002
DATE OF REVISION:
May 4, 2007
Control No.: 112007
_N_
_MARINOL_
_® _
_ _
Page 2 of 31
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................3
SUMMARY OF PRODUCT
INFORMATION..........................................................................3
INDICATIONS AND CLINICAL
USE......................................................................................3
CONTRAINDICATIONS
...........................................................................................................4
WARNINGS AND
PRECAUTIONS..........................................................................................5
DRUG ABUSE AND DEPENDENCE
.......................................................................................6
ADVERSE REACTIONS
...........................................................................................................8
DRUG
INTERACTIONS..........................................................................................................10
DOSAGE AND
ADMINISTRATION......................................................................................11
OVERDOSAGE
........................................................................................................................13
ACTION AND CLINICAL PHARMACOLOGY
....................................................................14
STORAGE AND
STABILITY..................................................................................................17
DOSAGE FORMS, COMPOSITION AND PACKAGING
.....................................................17
PART II: SCIENTIFIC INFORMATION
...........................................................................18
PHARMACEUTICAL INFORMATION
.................................................................................18
CLINICAL
TRIALS..